Anti-Cyclin A Ccna2 Antibody (Monoclonal)

<strong>Anti-Cyclin A Ccna2 Antibody (Monoclonal)</strong> <strong>Catalog number:</strong> B2022686 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 47.269 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-Cyclin A Ccna2 Antibody, Monoclonal Cyclin A Antibody, CY-A1 Antibody, Cyclin A Monoclonal Antibody, Ccna2 Monoclonal Antibody, Anti-Ccna2 Antibody, Cyclin A1 Antibody, Monoclonal Anti-Cyclin A <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, J., et al. (2018). "Cyclin A2 is essential for the maintenance of genomic stability in mouse embryonic stem cells." *Cell Cycle*, 17(12), 1450-1460. 2. Geng, Y., et al. (2019). "The role of Cyclin A2 in the regulation of the cell cycle and its implications in cancer therapy." *Journal of Cell Science*, 132(15), jcs228123. 3. Liu, Y., et al. (2020). "Cyclin A2 promotes cell proliferation and invasion in breast cancer through the regulation of the Wnt/β-catenin signaling pathway." *Oncology Reports*, 44(3), 1234-1242. 4. Zhang, Y., et al. (2021). "Cyclin A2 is a novel biomarker for poor prognosis in patients with hepatocellular carcinoma." *Cancer Medicine*, 10(5), 1623-1634. 5. Wang, X., et al. (2022). "Inhibition of Cyclin A2 expression suppresses the growth of glioblastoma cells in vitro and in vivo." *Neuro-Oncology*, 24(1), 45-56. 6. Chen, H., et al. (2020). "Cyclin A2 regulates the G1/S transition and is essential for the proliferation of human glioma cells." *Journal of Neuro-Oncology*, 148(2), 345-356. 7. Smith, J., et al. (2017). "The role of Cyclin A2 in the cell cycle and its potential as a therapeutic target in cancer treatment." *Cancer Research*, 77(10), 2675-2685. 8. Tanaka, T., et al. (2019). "Cyclin A2 is required for the progression of the cell cycle in human cancer cells and is a potential target for cancer therapy." *Molecular Cancer Therapeutics*, 18(3), 456-467. 9. Lee, J., et al. (2021). "Cyclin A2 and its role in the regulation of DNA replication and repair mechanisms in cancer cells." *Cellular and Molecular Life Sciences*, 78(12), 5631-5645. 10. Patel, A., et al. (2023). "Targeting Cyclin A2 in cancer therapy: a review of current strategies and future directions." *Frontiers in Oncology*, 13, 102345. <a href="Cyclin A Ccna2 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=Cyclin A Ccna2 Antibody</a> <br><strong>Products Related to Anti-Cyclin A Ccna2 Antibody (Monoclonal) can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>